ALLOGENE THERAPEUTICS INC's ticker is and the CUSIP is 019770906. A total of 4 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $210,537 | +286.1% | 47,100 | +173.8% | 0.00% | – |
| Q3 2023 | $54,524 | -50.8% | 17,200 | -22.9% | 0.00% | – |
| Q2 2023 | $110,831 | -15.3% | 22,300 | +7.2% | 0.00% | – |
| Q4 2022 | $130,832 | -84.8% | 20,800 | -74.0% | 0.00% | – |
| Q3 2022 | $863,000 | +281.9% | 79,900 | +303.5% | 0.00% | – |
| Q2 2022 | $226,000 | – | 19,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 40 | $115,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,300 | $38,000 | 0.00% |